心脏热素升高最常与创伤患者的2型心肌梗塞有关
John T Culhane1, Jillian Drogan2, Raymond I Okeke3
1Surgery, Saint Louis University School of Medicine, Saint Louis, USA.
Cureus
|July 3, 2023
概括
在创伤患者中,心脏热素 (cTn) 升高通常表明2型心肌梗塞 (MI) 由于氧气供需问题,而不是1型MI. 测量cTn有助于识别需要更密切的心脏监测和护理的患者.
科学领域:
- 心脏病学 心脏病学
- 创伤医学 创伤医学
- 临床诊断 临床诊断 临床诊断
背景情况:
- 心脏中位素 (cTn) 对于诊断心肌梗塞 (MI) 是至关重要的.
- 1型心脏病发作源于冠状动脉事件,而2型心脏病发作源于在创伤中常见的氧气供需不平衡.
- 创伤患者cTn升高可能并不总是意味着需要再血管化的MI.
研究的目的:
- 为了确定哪些创伤患者可以从cTn测量中受益.
- 为了确定哪些cTn升高的患者需要进一步的缺血检查.
主要方法:
- 从2017年7月到2020年12月,对创伤患者的回顾性队列研究,其cTn升高 (超过0.032 ng/ml).
- 收集了基线特征,对cTn病因的心脏病学判断,以及患者的生存率.
- 使用后勤回归来进行多变量分析.
主要成果:
- 1.1%的创伤患者 (147/13746) 的cTn升高; 55.1%缺乏明确的测试指示.
- 只有1.5%的评估患者被诊断为1型心脏病发作;66.4%的升高cTn被归因于2型心脏病发作 (供需不匹配).
- 在65.7%的病例中,增加的cTn独立预测死亡 (aOR2.6,p=0.002) 和管理变化发生.
结论:
- 创伤患者的cTn升高通常是由于创伤相关因素 (如心动减速,贫血) 的2型心脏病发作.
- 升高的cTn确定了需要密集监测和支持性心脏护理的患者,尽管再血管化从未被指示.
- 在创伤中更有选择性的cTn排序可以提高识别需要专业心脏护理的患者的特异性.
相关概念视频
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
203
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
203
Acute Coronary Syndrome I: Introduction
32
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
32
Acute Coronary Syndrome III: Diagnostic Studies
10
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
10
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
21
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
21
Myocarditis II: Clinical Features and Diagnostic Tests
12
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
12
Myocarditis III: Medical Management
9
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
9


